Gene · 8647
Papers3,310
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,310
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insilico generation of novel ligands for the inhibition of SARS-CoV-2 main protease (3CLpro) using deep learning. | Front Microbiol | 2023 | 37448573 | PubTator, text mining | PubMed |
| Maternal and Neonatal Outcomes in Intrahepatic Cholestasis of Pregnancy. | J Clin Med | 2023 | 37445442 | PubTator, text mining | PubMed |
| FXR Friend-ChIPs in the Enterohepatic System. | Semin Liver Dis | 2023 | 37442156 | PubTator, text mining | PubMed |
| Barriers and Facilitators to Pediatric Resident Education in the Emergency Department: A Qualitative Study. | Cureus | 2023 | 37425526 | PubTator, text mining | PubMed |
| Cell-based BSEP trans-inhibition: A novel, non-invasive test for diagnosis of antibody-induced BSEP deficiency. | JHEP Rep | 2023 | 37425215 | PubTator, text mining | PubMed |
| Hepatotoxicity of AKR1C3 Inhibitor BAY1128688: Findings from an Early Terminated Phase IIa Trial for the Treatment of Endometriosis. | Drugs R D | 2023 | 37422772 | PubTator, text mining | PubMed |
| The regulatory role of bile acid microbiota in the progression of liver cirrhosis. | Front Pharmacol | 2023 | 37416060 | PubTator, text mining | PubMed |
| Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma. | Nat Commun | 2023 | 37414763 | PubTator, text mining | PubMed |
| The Elk-3 target Abhd10 ameliorates hepatotoxic injury and fibrosis in alcoholic liver disease. | Commun Biol | 2023 | 37400491 | PubTator, text mining | PubMed |
| Licraside as novel potent FXR agonist for relieving cholestasis: structure-based drug discovery and biological evaluation studies. | Front Pharmacol | 2023 | 37397498 | PubTator, text mining | PubMed |
| Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP mice. | EBioMedicine | 2023 | 37379656 | PubTator, text mining | PubMed |
| Gut Microbiota-Mediated Pharmacokinetic Drug-Drug Interactions between Mycophenolic Acid and Trimethoprim-Sulfamethoxazole in Humans. | Pharmaceutics | 2023 | 37376182 | PubTator, text mining | PubMed |
| Hypericum perforatum L. and the Underlying Molecular Mechanisms for Its Choleretic, Cholagogue, and Regenerative Properties. | Pharmaceuticals (Basel) | 2023 | 37375834 | PubTator, text mining | PubMed |
| Current Therapies for Cholestatic Diseases. | Biomedicines | 2023 | 37371808 | PubTator, text mining | PubMed |
| Surgical versus Medical Management of Progressive Familial Intrahepatic Cholestasis-Case Compilation and Review of the Literature. | Children (Basel) | 2023 | 37371180 | PubTator, text mining | PubMed |
| Relevance of Bile Acids in Cholangiocarcinoma Pathogenesis: Critical Revision and Future Directions. | Cells | 2023 | 37371045 | PubTator, text mining | PubMed |
| Progressive familial intrahepatic cholestasis-outcome and time to transplant after biliary diversion according to genetic subtypes. | Front Surg | 2023 | 37361697 | PubTator, text mining | PubMed |
| Pharmacokinetic interaction of voriconazole and clarithromycin in Pakistani healthy male volunteers: a single dose, randomized, crossover, open-label study. | Front Pharmacol | 2023 | 37361220 | PubTator, text mining | PubMed |
| Using a Graph Convolutional Neural Network Model to Identify Bile Salt Export Pump Inhibitors. | ACS Omega | 2023 | 37360478 | PubTator, text mining | PubMed |
| Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine. | Acta Pharm Sin B | 2023 | 37360014 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8647/papers?page=17